Curative Biotechnology, Inc.
CUBT
$0.01
$0.000.00%
OTC PK
| 09/30/2025 | 03/31/2025 | 06/30/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.00% | -64.51% | -83.63% | -91.75% | 9,489.61% |
| Depreciation & Amortization | -0.46% | -17.05% | 0.00% | 53.85% | 53.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.53% | -62.91% | -62.77% | -79.39% | 9,525.56% |
| Operating Income | -10.53% | 62.91% | 62.77% | 79.39% | -9,525.56% |
| Income Before Tax | 13.30% | 56.48% | 50.40% | 79.63% | -10,057.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.30% | 56.48% | 50.40% | 79.63% | -10,057.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.30% | 56.48% | 50.40% | 79.63% | -10,057.00% |
| EBIT | -10.53% | 62.91% | 62.77% | 79.39% | -9,525.56% |
| EBITDA | -11.29% | 64.55% | 62.82% | 79.39% | -11,124.68% |
| EPS Basic | 20.00% | 8.33% | 61.67% | -84.06% | -- |
| Normalized Basic EPS | 16.67% | 62.50% | 54.84% | 88.37% | -- |
| EPS Diluted | 20.00% | 8.33% | 61.67% | -84.06% | -- |
| Normalized Diluted EPS | 16.67% | 62.50% | 54.84% | 88.37% | -- |
| Average Basic Shares Outstanding | 10.53% | 3.19% | 8.01% | 70.22% | 66.20% |
| Average Diluted Shares Outstanding | 10.53% | 3.19% | 8.01% | 70.22% | 66.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |